Literature DB >> 3896282

Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man.

U L Hulthén, P Bolli, F R Bühler.   

Abstract

The intent of this study was to determine whether or not increased calcium-influx-mediated vasoconstriction is a primary pathogenetic disturbance in essential hypertension. Ten normotensive subjects (NT) (aged 45 +/- 12 years) and 23 patients with essential hypertension (EH) were studied. Twelve of the patients (aged 42 +/- 12 years) were classified as having mild EH and 11 patients (aged 49 +/- 11 years) as having moderate EH. Forearm blood flow and intra-arterial blood pressure were measured. Forearm vascular resistance (FVR) was calculated under basal conditions, during reperfusion following 10 min arterial occlusion, and after infusion into the brachial artery of sodium nitroprusside (0.15 and 0.6 microgram min-1 100 ml-1 tissue for 2 min each) and the calcium-influx inhibitors nicardipine (5 and 40 micrograms min-1 100 ml-1 tissue for 1 min each) and verapamil (80 micrograms min-1 100 ml-1 tissue for 1 min). FVR after 10 min arterial occlusion was lower in mild EH than in moderate EH and still lower in NT. FVR was comparable in the three groups following infusion of maximal doses of sodium nitroprusside, nicardipine, and verapamil. To allow for the vasodilator response to arterial occlusion, the decrease in FVR measured after each drug was divided by that obtained after arterial occlusion in each individual. The adjusted vasodilator response to nicardipine and verapamil, but not to sodium nitroprusside, was greater in moderate EH than in NT and mild EH. In the latter two groups the adjusted vasodilator responses were comparable.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896282      PMCID: PMC1400786          DOI: 10.1111/j.1365-2125.1985.tb05144.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  A vascular abnormality in hypertension. A study of blood flow in the forearm.

Authors:  J CONWAY
Journal:  Circulation       Date:  1963-04       Impact factor: 29.690

2.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range.

Authors:  M Da Prada
Journal:  Life Sci       Date:  1976-10-15       Impact factor: 5.037

3.  The renin system: Variations in man measured by radioimmunoassay or bioassay.

Authors:  J E Sealey; J Gerten-Banes; J H Laragh
Journal:  Kidney Int       Date:  1972-04       Impact factor: 10.612

4.  Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension.

Authors:  A Takeshita; A L Mark
Journal:  Hypertension       Date:  1980 Sep-Oct       Impact factor: 10.190

5.  Response of forearm resistance vessels to verapamil and sodium nitroprusside in normotensive and hypertensive men: evidence for a functional abnormality of vascular smooth muscle in primary hypertension.

Authors:  B F Robinson; R J Dobbs; S Bayley
Journal:  Clin Sci (Lond)       Date:  1982-07       Impact factor: 6.124

6.  Verapamil and nifedipine inhibition of contractions induced by potassium and noradrenaline in human mesenteric arteries and veins.

Authors:  E Mikkelsen; K E Andersson; O Lederballe Pedersen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-02

7.  Comparative dilator effect of verapamil and sodium nitroprusside in forearm arterial bed and dorsal hand veins in man: functional differences between vascular smooth muscle in arterioles and veins.

Authors:  B F Robinson; J G Collier; R J Dobbs
Journal:  Cardiovasc Res       Date:  1979-01       Impact factor: 10.787

8.  Calcium influx mediated vasoconstriction: studies in patients with mild and moderate essential hypertension.

Authors:  U L Hulthén; P Bolli; F R Bühler
Journal:  J Hypertens Suppl       Date:  1983-12

9.  Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil.

Authors:  U L Hulthén; P Bolli; F W Amann; W Kiowski; F R Bühler
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

10.  The effect of nifedipine on isolated human peripheral vessels.

Authors:  E Mikkelsen; K E Andersson; O L Pedersen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-10
View more
  4 in total

Review 1.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

Review 2.  Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications.

Authors:  Monique P Curran; Dean M Robinson; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension.

Authors:  B Egan; R Panis; A Hinderliter; N Schork; S Julius
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

Review 4.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.